Table 1 (abstract P215). Summary of the significant results obtained with the three treatments

Frequency of the headache (gg/30 gg) pre e post-T (median)

From 9 to 3,5

(p=0.0002)^*

From 12 to 1

(p<0.0001)^*

From 4 to 3

(p=0.02)^*

Duration of the headache (h) pre e post-T(median)

From 8 to 5,4

(p=0.0002)^*

From 3,4 to 3

(p=0.58)

From 3,5 to 3

(p=0.18)

Nausea pre e post-T(median)

From 78,9% to 0% (p=0.0005)^*

From 0% to 0%

(p=0.49)

From 26,7% to 6,7% (p=0.22)

Photophobiapre e post-T(median)

From 32,5% to 26,5% (p=0.08)

From 28,6% to 0% (p=0.07)

From 75% to 0%

(p=0.03)^*

Phonophobia pre e post-T

(median)

From 40% to 0% (p=0.005)^*

From 37,5% to 0% (p=0.85)

From 100% to 25% (p=0.003)^*

Symptomatic drug consumption pre e post-T

(median)

From 4 to 1

(p=0.003)^*

From 8 to 1

(p=0.0002)^*

From 4,5 to 4

(p=0.15)

Items PedMidas°

^*4

^*2

^*1

Items CBCL 6-18°

^*1

^*1

^*1

Adverse and unpleasant effects (p=0.05)

6 (24%)

7 (70%)

4 (31%)

Satisfaction (*)

8,75

6

7

Positive secondary effects

7 (28%)

0 (0%)

0 (0%)